Alignment among public formularies in Canada, part 1.: H82-29/1-2017E-PDF
"This first report in the series provides insight into the degree of alignment among the formularies. Based on 2015 data, this analysis compares the overall drug listings and unpacks specific market segments including single- and multi-source drugs, high-cost drugs, and a specified list of essential medicines."--Executive summary, p. ii.
|Department/Agency||Patented Medicine Prices Review Board.|
|Title||Alignment among public formularies in Canada, part 1.|
|Other Language Editions||[French]|
|Electronic Document|| |
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.
Note: The URLs contained in this/these document(s) may no longer be functional
|Note||Issued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 1 : Aperçu général. Cover title.|
|Number of Pages||iii, 31 p. :|
|Subject Terms||Drugs, Drug insurance|
- Date modified: